Cardio Diagnostics Holdings, Inc. (CDIO)
1.65
-0.04
(-2.37%)
USD |
NASDAQ |
Nov 19, 16:00
1.63
-0.02
(-1.21%)
After-Hours: 20:00
Cardio Diagnostics Holdings Enterprise Value : 1.179M for Nov. 19, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 19, 2026 | 1.179M |
| November 18, 2026 | 1.298M |
| November 17, 2026 | 1.357M |
| November 16, 2026 | 1.594M |
| November 13, 2026 | 1.890M |
| November 12, 2026 | 1.830M |
| November 11, 2026 | 1.978M |
| November 10, 2026 | 1.801M |
| November 09, 2026 | 1.682M |
| November 06, 2026 | 1.182M |
| November 05, 2026 | 1.253M |
| November 04, 2026 | 1.164M |
| November 03, 2026 | 1.031M |
| November 02, 2026 | 1.238M |
| October 30, 2026 | 1.238M |
| October 29, 2026 | 1.475M |
| October 28, 2026 | 1.327M |
| October 27, 2026 | 1.327M |
| October 26, 2026 | 1.386M |
| October 23, 2026 | 1.298M |
| October 22, 2026 | 1.342M |
| October 21, 2026 | 1.534M |
| October 20, 2026 | 1.386M |
| October 19, 2026 | 1.150M |
| October 16, 2026 | 1.298M |
| Date | Value |
|---|---|
| October 15, 2026 | 1.505M |
| October 14, 2026 | 1.238M |
| October 13, 2026 | 1.475M |
| October 12, 2026 | 1.564M |
| October 09, 2026 | 1.830M |
| October 08, 2026 | 1.801M |
| October 07, 2026 | 2.097M |
| October 06, 2026 | 2.215M |
| October 05, 2026 | 2.393M |
| October 02, 2026 | 2.097M |
| October 01, 2026 | 1.978M |
| September 30, 2026 | 1.919M |
| September 29, 2026 | 0.3173M |
| September 28, 2026 | 0.3877M |
| September 25, 2026 | 0.554M |
| September 24, 2026 | 0.4356M |
| September 23, 2026 | 0.4652M |
| September 22, 2026 | 0.4652M |
| September 21, 2026 | 0.4652M |
| September 18, 2026 | 0.7612M |
| September 17, 2026 | 0.7908M |
| September 16, 2026 | 0.702M |
| September 15, 2026 | 0.702M |
| September 14, 2026 | 0.9092M |
| September 11, 2026 | 0.7908M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Tenax Therapeutics, Inc. | -50.43M |
| Exicure, Inc. | 4.529M |
| Century Therapeutics, Inc. | 159.53M |
| Absci Corp. | 1.236B |
| Celularity, Inc. | 82.95M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.732M |
| Revenue (Quarterly) | 0.0036M |
| Total Expenses (Quarterly) | 1.736M |
| EPS Diluted (Quarterly) | -0.5854 |
| Gross Profit Margin (Quarterly) | -1.30K% |
| Profit Margin (Quarterly) | -48.12K% |
| Earnings Yield | -153.0% |
| Normalized Earnings Yield | -153.01 |